FDA ignores current science to give Juul a pass

Not surprisingly, on July 17, 2025, FDA authorized the sale of Juul tobacco and menthol e-cigarettes.  I wish I could say that I am “not surprised” because during the 2024 campaign President Trump announced that he would “save vaping,” but, on reading FDA’s scientific justification (the Technical Product Lead report [TPL]), I found that theContinue reading “FDA ignores current science to give Juul a pass”

New WHO report details progress and problems in global tobacco control

In June 2025 the WHO released its new comprehensive WHO report on the global tobacco epidemic, 2025: Warning about the dangers of tobacco. The report contains detailed country-specific analysis and statistics about progress in reducing tobacco use, policies, and industry opposition. It is a valuable reference document. It recognizes that Overall, while progress since 2007Continue reading “New WHO report details progress and problems in global tobacco control”

Cass Wheeler, former CEO of American Heart Association and a wonderful mentor, died

I was saddened to learn that on June 20, 2025, Cass Wheeler died, just short of his 85th birthday. Cass spent 35 years at the American Heart Association, serving as CEO from 1998 through 2008. I don’t remember when or how I first met Cass, but he became an important ally and mentor. As theContinue reading “Cass Wheeler, former CEO of American Heart Association and a wonderful mentor, died”

San Francisco’s proposed Recovery First Drug Policy is a good idea

In September, San Francisco Supervisor Matt Dorsey introduced his “Recovery First Drug Policy” that states “The cessation of illicit drug use and attainment of long-term Recovery from Substance Use Disorders shall be the primary objective of the City’s drug policy.” The policy allows for other steps, including harm reduction, as part of a comprehensive approachContinue reading “San Francisco’s proposed Recovery First Drug Policy is a good idea”

Trump gives Big Tobacco a big gift: He killed the National Youth Tobacco Survey, blinding public, researchers, and policy makers to the effects of changing tobacco industry products and practices

The now-shuttered CDC Office on Smoking and Health (OSH) has conducted the National Youth Tobacco Survey since 1999.  The survey provides important surveillance about how youth tobacco use is changing.  After Congress created the FDA Center for Tobacco Products, it partnered with CDC to expand the scope and depth of the survey, including increasing detailsContinue reading “Trump gives Big Tobacco a big gift: He killed the National Youth Tobacco Survey, blinding public, researchers, and policy makers to the effects of changing tobacco industry products and practices”

Three year study finds that fourth-generation e-cigarettes like Juul associated with continued smoking and vaping

Most studies of the association between e-cigarette use and smoking and nicotine cessation have been conducted with the earlier generation e-cigarettes, which do not deliver nicotine as effectively as the fourth generation e-cigarettes pioneered by Juul. (These e-cigarettes use protonated nicotine [also called nicotine salts] to increase nicotine delivery to the user.) Our meta-analysis ofContinue reading “Three year study finds that fourth-generation e-cigarettes like Juul associated with continued smoking and vaping”

Forewarned is for-armed: Tobacco, food and alcohol industry efforts to intimidate health advocates and researchers

As someone who has spent decades doing public health research and advocacy on tobacco and other issues, I have been the object of several attacks and intimidation efforts, including, among other things, attacks on my professional credibility, litigation, and pressure on funders. Fortunately, thanks to a strong support network, including from the University of California,Continue reading “Forewarned is for-armed: Tobacco, food and alcohol industry efforts to intimidate health advocates and researchers”

Historical and political context for Philip Morris International’s continuing medical education courses on harm reduction: Implications for current product regulation

In mid-2024 Drs. Robert Jackler, Pam Ling and others learned that the for-profit medical company Medcape was offering a continuing medical education course on tobacco harm reduction sponsored by Philip Morris International that promoted the industry position that smokers could reduce risk by switching from cigarettes to “less risky” products, such as smokeless tobacco. MostContinue reading “Historical and political context for Philip Morris International’s continuing medical education courses on harm reduction: Implications for current product regulation”

Heated tobacco products increase risk of metabolic syndrome more than smoking

The tobacco companies have been aggressively promoting heated tobacco products (HTP), including Philip Morris IQOS, BAT’s glo and JTI’s Ploom, as safer alternatives to cigarettes as part of the companies’ efforts to reposition themselves as “part of the solution” to the tobacco problem. Similar to e-cigarettes, they argue that these products are safer because theContinue reading “Heated tobacco products increase risk of metabolic syndrome more than smoking”

Dual use is not an intermediate condition on the way from cigarettes to “switching completely” or quitting

Discussion of potential harm reduction associated with the use of e-cigarettes assumes that smokers will “switch completely” from cigarettes to e-cigarettes or stop both tobacco products. Advocates of this view, including the US FDA, recognize and accept that this process may include a period of dual use in which smokers use both products. Now JosefContinue reading “Dual use is not an intermediate condition on the way from cigarettes to “switching completely” or quitting”